Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

671.00p
   
  • Change Today:
    -29.00p
  • 52 Week High: 1,145.00
  • 52 Week Low: 412.50
  • Currency: UK Pounds
  • Shares Issued: 6.90m
  • Volume: 11,144
  • Market Cap: £46.28m
  • RiskGrade: 340
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,259,648
Vladislav Sandler Ph.D. 103,862 £696,914
Peter Redmond 13,991 £93,880

Major Shareholders

Notifier** Holding Value*
David John Smith 416,530 £2,794,916
Alexis Sandler 187,726 £1,259,642
Dr Vladislav Sandler 103,862 £696,914
Optiva Securities Limited 70,329 £471,908
Flascherberg Capital Anstalt 69,991 £469,640
Craig Auringer 59,593 £399,869
HSBC Client Holdings Nominee (UK) Limited 45,160 £303,024
Ron Valk 42,828 £287,376
Samantha Bauer 42,706 £286,557
Plum Capital 29,232 £196,147
43 North LLC 28,429 £190,759
Abdelatif LACHAB 6,500 £43,615
Wayne Gibson 6,500 £43,615

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 671.00p
Change Today -29.00p
% Change -4.14 %
52 Week High 1,145.00
52 Week Low 412.50
Volume 11,144
Shares Issued 6.90m
Market Cap £46.28m
Beta 0.01
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.58% below the market average51.58% below the market average51.58% below the market average51.58% below the market average51.58% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
66.34% above the market average66.34% above the market average66.34% above the market average66.34% above the market average66.34% above the market average
90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average90.70% above the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 27-Oct-2026

Time Volume / Share Price
16:35 1,228 @ 671.00p
16:35 895 @ 671.00p
16:35 105 @ 671.00p
16:35 112 @ 671.00p
16:35 9 @ 671.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page